According to ODI Pharma AB latest financial reports the cash on hand of 6OD is $636.02K, an decrease of -11.88% to 2022. At the end of 2022 company had $721.73K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $636.02K | -11.88% |
2022 | $721.73K | -49.62% |
2021 | $1.43M | -28.71% |
2020 | $2.01M | 315.38% |
2019 | $483.76K | 11.72% |
2019 | $433.02K | - |